learn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
Search
forLearn
5 / 801 resultslearn Epidermal Growth Factor
learn Stem Cell Factor
learn sh-Polypeptide-7
learn procapil
Research
5 / 800 resultsresearch Dietary Supplement and Prescription Omega-3 Fatty Acid Products Use among Iraqi Consumers in Kirkuk City
Consumers in Kirkuk City use both prescription and nonprescription omega-3 products, but need better understanding of their differences.
research Bone broth extracts importance for consumers health
Bone broth may improve health and prevent diseases.
research A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.
research Regulating Healthy Gender: Surgical Body Modification among Transgender and Cisgender Consumers
Transgender individuals face more barriers and less autonomy in surgical body modifications compared to cisgender individuals.
research Development of predictive regression model for perceived hair breakage in Indian consumers
The model predicts hair breakage based on key hair properties and helps product developers.
Community Join
5 / 1000+ resultscommunity Nicotinamide Riboside Experience
Nicotinamide Riboside (NR) significantly reduced hair loss for the user. They found science.bio's NR to be effective, unlike other brands.
community Hair Growth Caps and Helmets Research
Hair growth caps and helmets using low-level laser therapy (LLLT) show potential for treating androgenetic alopecia, but more research is needed. Users often combine these devices with treatments like minoxidil and finasteride for better results.
community Korea launches 1st OTC hair loss drug
Korea launched its first OTC oral hair loss drug, dexpanthenol B5. Users discuss its anti-oxidative and anti-inflammatory effects but note a lack of efficacy studies.
community How far away are we from scalp/hair follicle cloning for an essentially unlimited transplant supply? And would prior transplants affect eligibility?
Hair/scalp cloning for unlimited transplants is likely a decade away, with prior transplants not significantly affecting future options. Advances in AI and research in wound-induced hair neogenesis are promising, but infrastructure and technology constraints remain challenges.
community The expected timeline for PP405 - Next update at AAD Annual Meeting in March 2026 ?
A new hair loss treatment, PP405, showed promising Phase 2a results with 31% of patients experiencing over 20% hair density increase without systemic absorption, avoiding hormonal side effects. The treatment is expected to be expensive, with Phase 3 trials starting mid-2026, and there is skepticism about the data's strength.